Canada markets closed

NovelStem International Corp. (NSTM)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.22000.0000 (0.00%)
At close: 09:30AM EDT
Full screen
Trade prices are not sourced from all markets
Previous Close0.2200
Open0.2200
Bid0.0000 x 0
Ask0.0000 x 0
Day's Range0.2200 - 0.2200
52 Week Range0.0300 - 0.3300
Volume1,000
Avg. Volume22,059
Market Cap4.981M
Beta (5Y Monthly)0.37
PE Ratio (TTM)1.16
EPS (TTM)0.1900
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateApr 02, 2018
1y Target EstN/A
  • Newsfile

    NovelStem Announces FDA Pre-Submission and EMA In Vitro Diagnostic Device Filing for Revolutionary Life-Saving, Treatment-Changing Diagnostic Device by 30%-Owned NewStem, Ltd

    NewStem is the only company worldwide to develop therapeutics and diagnostics products based on haploid human embryonic stem cell research Jerusalem, Israel and Boca Raton, Florida--(Newsfile Corp. - April 11, 2022) - NovelStem International Corp. (OTC Pink: NSTM), a biotechnology company focused on the stem cell-based technology platform developed by 30%-owned, Israel-based NewStem Ltd., today announced NewStem's filing of a pre-submission to the FDA for a De Novo Request and an in vitro diagno

  • Newsfile

    NovelStem Reviews Efforts to Maximize Value from Legacy Entertainment Asset

    Boca Raton, Florida--(Newsfile Corp. - February 15, 2022) - NovelStem International Corp. (OTC Pink: NSTM), a biotechnology company focused on the stem cell-based technology platform developed by 30%-owned, Israel-based NewStem, Ltd., today reviewed progress regarding ongoing efforts to maximize shareholder value from its legacy 50% ownership in Netco Partners, which owns the Net Force publishing and entertainment franchise.NovelStem Chairman, Jan Loeb, commented, "We have initiated an arbitrati

  • Newsfile

    NovelStem Announces NewStem, Ltd. Was Selected by Illumina for its Global Illumina Accelerator

    Boca Raton, Florida and Jerusalem, Israel--(Newsfile Corp. - September 20, 2021) - NovelStem International Corp. (OTC Pink: NSTM), a biotechnology company focused on the stem cell-based technology platform developed by 30%-owned Israel-based, NewStem, Ltd., announced that NewStem, along with six other genomic companies, was selected by Illumina for its global Illumina Accelerator. Illumina Accelerator is a company creation engine that focuses on partnering with and building companies with unique